Citrine Medicine Funding: $80M Raised, Series A (2020)
Citrine Medicine is based in Huangpu, Shanghai, China. It has raised $80M in total funding. Latest round: Series A.
Citrine Medicine funding overview
Citrine Medicine is based in Huangpu, Shanghai, China. Citrine Medicine has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2020. The round record for Citrine Medicine runs through 2020; nothing later has been disclosed. Investors on record include Quan Capital, 3H Health Investment, WU Capital, Eight Roads, F-Prime Capital, Vivo Capital. 6 distinct backers are named across the disclosed rounds.
Citrine Medicine at a glance
Total raised
$80M
Latest round
Series A
Latest round date
January 2020
Headquarters
Huangpu, Shanghai, China
Notable investors
Quan Capital, 3H Health Investment, WU Capital, Eight Roads, F-Prime Capital, Vivo Capital
Frequently asked about Citrine Medicine funding
How much has Citrine Medicine raised?
Citrine Medicine has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Citrine Medicine?
Quan Capital, 3H Health Investment, WU Capital, Eight Roads, F-Prime Capital, Vivo Capital are named among the investors backing Citrine Medicine.
What was the latest Citrine Medicine funding round?
The most recent disclosed round is a Series A, announced in January 2020.
Where is Citrine Medicine based?
Citrine Medicine is based in Huangpu, Shanghai, China.
When did Citrine Medicine last raise?
The last disclosed Citrine Medicine round closed in January 2020 at Series A.
Citrine Medicine totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Huangpu below to benchmark round size and investor mix.
